1 |
Vahora H, Khan MA, Alalami U, Hussain A. The potential role of nitric oxide in halting cancer progression through chemoprevention. J. Cancer Prev. 21: 1-12 (2016)
DOI
|
2 |
Iwakiri Y. Nitric oxide in liver fibrosis: The role of inducible nitric oxide synthase. Clin. Mol. Hepatol. 21: 319-325 (2015)
DOI
|
3 |
Olszowski T, Baranowska-Bosiacka I, Gutowska I, Chlubek D. Pro-inflammatory properties of cadmium. Acta. Biochim. Pol. 59: 475-482 (2012)
|
4 |
Ma N, Kawanishi M, Hiraku Y, Murata M, Huang GW, Huang Y, Luo DZ, Mo WG, Kawanishi S. Reactive nitrogen species-dependent DNA damage in EBV-associated nasopharyngeal carcinoma: The relation to STAT3 activation and EGFR expression. Int. J. Cancer 122: 2517-2525 (2008)
DOI
|
5 |
Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E, Ben-Neriah Y. NF-kappaB functions as a tumor promoter in inflammation-associated cancer. Nature 431: 461-466 (2004)
DOI
|
6 |
Bannon A, Zhang SD, Schock BC, Ennis M. Cystic fibrosis from laboratory to bedside: The role of A20 in NF--mediated inflammation. Med. Princ. Pract. 24: 301-310 (2015)
DOI
|
7 |
Pamukcu B, Lip GY, Shantsila E. The nuclear factor-kappa B pathway in atherosclerosis: A potential therapeutic target for atherothrombotic vascular disease. Thromb. Res. 128: 117-123 (2011)
DOI
|
8 |
Neumann M, Naumann M. Beyond IkappaBs: Alternative regulation of NF-kappaB activity. FASEB J. 21: 2642-2654 (2007)
DOI
|
9 |
Tokunaga F. Linear ubiquitination-mediated NF- regulation and its related disorders. J. Biochem. 154: 313-323 (2013)
DOI
|
10 |
Maine GN, Mao X, Komarck CM, Burstein E. COMMD1 promotes the ubiquitination of NF-kappaB subunits through a cullincontaining ubiquitin ligase. EMBO J. 26: 436-447 (2007)
DOI
|
11 |
Das UN. Molecular basis of health and disease. Springer publishing, NewYork, USA. pp. 15-16. (2011)
|
12 |
Coussens LM, Werb Z. Inflammation and cancer. Nature 420: 860-867 (2002)
DOI
|
13 |
Murata M, Thanan R, Ma N, Kawanishi S. Role of nitrative and oxidative DNA damage in inflammation-related carcinogenesis. J. Biomed. Biotechnol. 623019 (2012)
|
14 |
Baltimore D. Discovering NF-kappaB. Cold Spring Harb. Perspect. Biol. 1: a000026 (2009)
|
15 |
Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell 132: 344-362 (2008)
DOI
|
16 |
Staudt LM. Oncogenic activation of NF-kappaB. Cold Spring Harb. Perspect. Biol. 2: a000109 (2010)
|
17 |
Ben-Neriah Y, Karin M. Inflammation meets cancer, with NF-kB as the matchmaker. Nat. Immunol. 12: 715-723 (2011)
DOI
|
18 |
Choi SZ, Yang MS, Choi SU, Lee KR. Cytotoxic terpenes and lignans from the roots of Ainsliaea acerifolia. Arch. Pharm. Res. 29: 203-208 (2006)
DOI
|
19 |
Brasier AR. The NF-kappaB regulatory network. Cardiovasc. Toxicol. 6: 111-130 (2006)
DOI
|
20 |
Mishra BB, Tiwari VK. Natural products: an evolving role in future drug discovery. Eur. J. Med. Chem. 46: 4769-4807 (2011)
DOI
|
21 |
Jung CM, Kwon HC, Choi SZ, Lee JH, Lee DJ, Ryu SN, Lee KR. Phytochemical constituents of Ainsliaea acerifolia. Korean J. Pharmacogn. 31: 125-129 (2000)
|
22 |
Lee EW, Kim TW, Kim HS, Park YM, Kim SH, Im MH, Kwak JH, Kim TH. Antioxidant and a-glucosidase inhibitory effects of ethanolic extract of Ainsliaea acerifolia and organic solvent-soluble fractions. Korean J. Food Preserv. 22: 275-280 (2015)
DOI
|
23 |
Moon HI, Ji OP, Shin MS. Effects of compounds isolated from Ainsliaea acerifolia on the hepatic alcohol dehydrogenase activity. J. Appl. Biol. Chem. 42: 162-165 (1999)
|
24 |
Moon HI, Ji OP, Moon SH, Shin MS. Effect of Ainsliaea acerifolia fraction extract on alcohol dehydrogenase activity. J. Appl. Biol. Chem. 41: 447-450 (1998)
|
25 |
Shin SG, Kang JK, Lee KR, Lee HW, Han JW, Choi WS. Suppression of inducible nitric oxide synthase and cyclooxygenase-2 expression in RAW 264.7 macrophages by sesquiterpene lactones. J. Toxicol. Environ. Health A. 68: 2119-2131 (2005)
DOI
|
26 |
Ando M, Kusaka H, Ohara H, Takase K, Yamaoka H, Yanagi Y. Studies on the syntheses of sesquiterpene lactones. 11. The syntheses of 3-epizaluzanin C zaluzanin C, zaluzanin D, and related compounds 3a-hydroxyguaia-1(10),4 (15),11(13)-trieno-12,6a-lactone and 3a-hydroxyguaia-4(15),9,11(13)-trieno-12, 6a-lactone. J. Org. Chem. 54: 1952-1960 (1989)
DOI
|